ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/04/2019
Back to search
Official data from USPTO
ACCRETAMAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACCRETAMAB
ST13
US500000077178675Class
5, 40, 42
Filing
77178675
Registration
3653037
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
09/04/2019
Trademark type
Word
Nice classes
5, 40, 42
Filing date
05/11/2007
Registration date
07/14/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/10/2019
Last transaction
04/10/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
TOKYO, JP
Examiner
FAHRENKOPF, PAUL
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
KYOWA KIRIN CO., LTD.
KYOWA HAKKO KIRIN CO., LTD.
KYOWA HAKKO KOGYO CO., LTD.
Representatives
Kaushal R. Odedra ODEDRA LAW OFFICE, PLLC
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Host cells for medical or clinical use; cells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticalscentral nervous system depressantspreparations for ophthalmic useanti-histaminicscardiotonicsarrhythmia treating agentsdiureticshypotensorsprophylactic for the treatment of asthmaantitussives and expectorantsstomachics and digestivesantacidshormonespituitary hormones for the treatment of infertilitythyroid hormones for the treatment of hyperthyroidismanabolic hormones for the treatment of aplastic anemia and osteoporosiscorticosteroids for treatment of hypopituitarismcongenital adrenal hyperplasiarheumatoid arthritisrheumatic fevercrohn's diseasechronic active hepatitisestrogen and progesterone used as combined oral contraceptivesurinary antisepticsanalgesicsanti-itching agentscataplasms for the treatment of bruiseslumbago and stiff shoulderpharmaceutical preparations used to treat hair disordersvitamin preparationsfood enriching agents for treating vitamin deficienciesanti-coagulantsenzyme preparations for control of malabsorption and diarrheaanti-cancer preparationsanti-sarcoma preparationsantibiotics and their preparations for the treatment of infectious diseasesantituberculotic agentsinfluenza vaccinesdiphtheria vaccinestetanus vaccinesgas gangrene vaccinesJapanese encephalitis vaccinesin vitro tetrodotoxines for medical useantiprotozoals for the treatment of trichomoniasis and dermatophytosisanthelmintics for the treatment of threadworm and toxoplasmaosisnaturally occurring drugs for treating peptic ulcerscharred drugs for treating peptic ulcersmoxa for treating peptic ulcersveterinary drugs for the treatment of distemper in dogsdistomatosis in dogscoccidian in chickensdysentery in pigsgermination controllers and plant rearing agentsherbicidesfungicidesinsecticidesbactericides and rodenticides for domestic and or agricultural useantisepticsdrugs for arteriosclerosisoncostatic drugs for the treatment for cancermultienzyme digestants for in vivo useantifungal antibiotics for treating trichomoniasis and dermatophytosisanti parkinsonism drugsminor tranquilizersanti anxiety agentsmedicinal preparations for the treatment of the central nervous systemthe respiratory tract and the cardiovascular systemanti-bacterial preparationsmonolithic preparationsmedicinal preparations for the treatment of peptic ulcersanti-inflammatory preparationsanalgesic preparationscephalosporincocarboxylase preparationsglutathione preparationspreparations for improving the metabolism and the peripheral circulationplasma substitutes and extracorporeal circulation flow improvement preparationsdiuretic and anti-hypertensive preparationsin vitro diagnostic reagents for medical usein vitro extra corporeal diagnostic reagents for medical usein vitro x-ray contrast agents for medical usein vitro diagnostic mediapharmaceutical preparations for the treatment of insomnia and other sleep related diseases
Class 40
Contract manufacturing service in the field of antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of host cells; contract extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals; providing information in the field of manufacturing technology in the field of antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals technical consultation in the field of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals
Class 42
Development of new products for others in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells; providing technical information in the field of development of new products in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells; technical consultation in the field of development of new products in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells
Publications
History of USPTO decisions and trademark events.
40 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/10/2019
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/10/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/10/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
04/08/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/14/2018
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/05/2015
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
08/05/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/05/2015
ES8R
TEAS SECTION 8 RECEIVED
07/01/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2009
PUBO
PUBLISHED FOR OPPOSITION
04/28/2009
NPUB
NOTICE OF PUBLICATION
04/08/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/23/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/24/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2009
PAPER RECEIVED
02/23/2009
CNSI
INQUIRY AS TO SUSPENSION MAILED
02/10/2009
CNSI
SUSPENSION INQUIRY WRITTEN
02/09/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/09/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2009
PAPER RECEIVED
02/06/2009
CNSI
INQUIRY AS TO SUSPENSION MAILED
01/12/2009
CNSI
SUSPENSION INQUIRY WRITTEN
01/11/2009
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/11/2008
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/19/2008
CNSL
LETTER OF SUSPENSION MAILED
06/11/2008
CNSL
SUSPENSION LETTER WRITTEN
06/11/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/10/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2008
PAPER RECEIVED
06/09/2008
CNSI
INQUIRY AS TO SUSPENSION MAILED
03/26/2008
CNSI
SUSPENSION INQUIRY WRITTEN
03/25/2008
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/24/2008
ALIE
ASSIGNED TO LIE
02/24/2008
CNSL
LETTER OF SUSPENSION MAILED
08/24/2007
CNSL
SUSPENSION LETTER WRITTEN
08/24/2007
DOCK
ASSIGNED TO EXAMINER
08/24/2007
NWAP
NEW APPLICATION ENTERED
05/16/2007
Continuous trademark protection
Get notified about every new filing that threatens ACCRETAMAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.